Oh Absolutely. MHRA is validating NWBO ECA based on pooled data from clinical trials and even lower standards of RWE from treatment experience that will help expand the label onc approved. The announcement of the Regulatory Changes by the MHRA is a smoking gun that NWBO drug will be approved.
Market Data 
Markets 
AI
